Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2022
[Securing the information system of health care organisations]B Fleury, P Loudenot, M Suszko, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 12, 2013
A life-threatening dichlorophen poisoning case: clinical features and kinetics studyJ Langrand, C Moesch, R Le Grand, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 29, 2014
Toxic hepatitis induced by a herbal medicine: Tinospora crispaJ Langrand, H Regnault, X Cachet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 5, 2018
Rare histologic types of rectal cancer: A monocentric cases series reportA Vallard, P Diao, M-A Garcia, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 3, 2019
Exposures associated with making or playing with viscoelastic polymer toys known as Slime: a retrospective case series from French Poison Control CentresM Labadie, J Langrand, G Leroux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2022
[Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care]C Miran, E Bonnet, C Lafont, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 25, 2016
[Radiotherapy phase I trials' methodology: Features]R Rivoirard, A Vallard, J Langrand-Escure, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2016
Conflict of interests for radiation oncologists: Harnessing disclosures from policy to realityJ-B Guy, A Vallard, S Espenel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 23, 2021
Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experienceO Ogorodniitchouk, J Aunier, A Bousarsar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Pageof 3